Streamlining Patient Access to Cell and Gene Therapies
Gain a deeper understanding of the vital role patient services play in successful CGT launches. Discover the importance of flexible patient support and learn about the convenience offered by delivering services through a centralized hub.
Speakers:
- Dale Hanna: Director, Cell and Gene Therapy Solutions, Cencora
- Chris Came: VP, Relationship Management, TrakCel
- Vickie Simpson: Senior Manager, Operations, Patient Services, Cencora
In addition, to further enhance your knowledge, download our informative playbook “Keys to improving patient access and support services for cell and gene therapies”.
The rapid growth of the cell and gene therapy (CGT) sector is revolutionizing disease treatment, but patients
often face unique challenges in accessing these transformative therapies.
To address this, pharma brands must provide crucial support to help patients overcome barriers. In our thought-provoking webinar, we bring together experts from Cencora and our esteemed partner, TrakCel. Together, we shed light on the obstacles patients encounter when seeking CGTs, explore how technology and patient services can empower manufacturers and clinical teams, and share invaluable insights from commercialization experiences that underscore the significance of wrap-around services for patient support.
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.